FOLD
NEUTRALM&AAmicus Therapeutics, Inc.
Price
$14.30
+0.00%Score12.0Top Tier
Signals5/8 DNA1/13 Act · 0/4 Risk
SentimentNEUTRALScore: 8
Volume0.6xvs 20d avg
Analysis
FOLD is currently in a 'Merger Arbitrage' regime following BioMarin's (BMRN) December 2025 agreement to acquire the company for $14.50 per share in cash. The 'Quiet Storm' and 'Perfect Stack' signals are technical artifacts of the stock being pegged to this deal price, resulting in artificially compressed volatility (3.6% annualized). While the technicals suggest a breakout, the upside is structurally capped at the $14.50 acquisition price, leaving a ~1.4% arbitrage spread as the primary trade.
Fired Signals
ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKSELLER FATIGUE
© 2026 Signal52 • For educational purposes only